David Burleigh
Impact in
- Gastroenterology top 1%
- Gastrointestinal motility and disorders
- Gastroesophageal reflux and treatments
- Rheumatology top 5%
- Pelvic floor disorders treatments
Papers in
-
- Gastrointestinal motility and disorders 6
-
- Neuropeptides and Animal Physiology 12
- Co-authors
- R. A. BormanRichard A. BormanA G ParksSimon de LusignanJohn B. FurnessR J NichollsMichael SwashRobert J. Hinchliffe
- Journals
- Journal of Pharmacy and Pharmacology (8 papers)European Journal of Pharmacology (7 papers)Gastroenterology (6 papers)British Journal of Pharmacology (4 papers)Neuropeptides (2 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
David Burleigh
42 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 104
- Gastroenterology 370
- Rheumatology 286
- Cellular and Molecular Neuroscience 321
- Surgery 639
- Pharmacy 49
Countries citing papers authored by David Burleigh
This map shows the geographic impact of David Burleigh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Burleigh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Burleigh more than expected).
Fields of papers citing papers by David Burleigh
This network shows the impact of papers produced by David Burleigh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Burleigh. The network helps show where David Burleigh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Burleigh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Ontologies to improve the identification of ethnicity in people with Type 2 diabetes | 2016 | 2 |
| 2 | 2005 | 36 | |
| 3 | 2001 | 1 | |
| 4 | 2000 | 6 | |
| 5 | 1997 | 21 | |
| 6 | 1997 | 16 | |
| 7 | 1997 | 17 | |
| 8 | 1994 | 2 | |
| 9 | 1993 | 14 | |
| 10 | 1993 | 49 | |
| 11 | 1992 | 123 | |
| 12 | 1992 | 63 | |
| 13 | 1991 | 18 | |
| 14 | 1991 | 84 | |
| 15 | 1990 | 23 | |
| 16 | 1990 | 12 | |
| 17 | More two-minute mysteries | 1988 | 0 |
| 18 | 1988 | 57 | |
| 19 | 1986 | 18 | |
| 20 | 1983 | 59 |
About David Burleigh
David Burleigh is a scholar working on Gastroenterology, Cellular and Molecular Neuroscience, Pharmacy, Endocrinology, Diabetes and Metabolism and Rheumatology, having authored 43 papers that have together received 1.5k indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (12 papers), Ion channel regulation and function (7 papers), Gastrointestinal motility and disorders (6 papers), Pelvic floor disorders treatments (5 papers), Pain Mechanisms and Treatments (5 papers), Diabetes Management and Education (4 papers), Pharmacological Receptor Mechanisms and Effects (4 papers) and Congenital gastrointestinal and neural anomalies (4 papers). The work is most often cited by research in Gastroenterology (370 citations), Rheumatology (286 citations), Cellular and Molecular Neuroscience (321 citations), Surgery (639 citations) and Pharmacy (49 citations). David Burleigh has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include R. A. Borman, Richard A. Borman, A G Parks, Simon de Lusignan, John B. Furness, R J Nicholls, Michael Swash, Robert J. Hinchliffe, Jack Brownrigg and Peter J. Lunniss. Their work appears in journals such as Journal of Pharmacy and Pharmacology, European Journal of Pharmacology, Gastroenterology, British Journal of Pharmacology and Neuropeptides.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.